XORTX Therapeutics Inc. (XRTX)
NASDAQ: XRTX · Real-Time Price · USD
0.9600
+0.0570 (6.31%)
At close: Apr 2, 2025, 4:00 PM
0.9602
+0.0002 (0.02%)
After-hours: Apr 2, 2025, 6:30 PM EDT

XORTX Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Apr '25 Dec '24 Dec '23 Dec '22 Jan '22 Dec '20 2015 - 2019
Market Capitalization
44412269
Upgrade
Market Cap Growth
-6.84%-6.84%-63.14%-53.60%177.78%19.02%
Upgrade
Enterprise Value
12-13229
Upgrade
Last Close Price
0.901.132.317.2718.4512.26
Upgrade
PB Ratio
1.141.230.951.701.947.35
Upgrade
P/TBV Ratio
1.301.300.981.751.979.04
Upgrade
Debt / Equity Ratio
0.010.010.000.01--
Upgrade
Quick Ratio
3.293.294.256.9626.970.18
Upgrade
Current Ratio
3.533.534.937.2128.781.99
Upgrade
Return on Equity (ROE)
-83.06%-83.06%-37.08%-76.43%-22.25%-245.97%
Upgrade
Return on Assets (ROA)
-34.21%-34.21%-34.72%-38.82%-15.04%-40.80%
Upgrade
Return on Capital (ROIC)
-40.74%-40.74%-52.83%-56.97%-20.34%-125.84%
Upgrade
Earnings Yield
-86.93%-81.03%-49.17%-64.82%-6.15%-13.91%
Upgrade
FCF Yield
-96.51%-89.96%-150.08%-68.74%-18.71%-7.89%
Upgrade
Buyback Yield / Dilution
-45.25%-45.25%-33.91%-35.25%-47.77%-24.34%
Upgrade
Updated Nov 15, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q